Treatment of type III hyperlipoproteinemia with four different treatment regimensB.J. Hoogwerf; J.P. Bantle; K. Kuba; I.D. Frantz Jr.; D.B. Hunninghake · 1984

Long-term treatment of type III hyperlipoproteinemia with clofibrateP.M.J. Stuyt; P.N.M. Demacker; A. Van 'T Laar · 1981

Effect of fenofibrate treatment on type III hyperlipoproteinemiaJean-Charles Fruchart; Jean Davignon; Jean-Marie Bard; Anne-Marie Grothe; Angèle Richard; Catherine Fievet · 1987

Treatment of type III hyperlipoproteinemia with bromocriptine in a premenopausal woman with hyperprolactinemiaJohn L. Stock; Norio Higano; Roger W. Robinson; Richard Haas · 1986

Severe hypertriglyceridemia during treatment of acute lymphoblastic leukemia associated with type III hyperlipoproteinemiaYamada, Yuji; Shima, Haruko; Shibata, Hironori; Ishii, Tomohiro; Hasegawa, Tomonobu; Shimada, Hiroyuki · Pediatric Blood & Cancer · 2017

EFFECT OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE III HYPERLIPOPROTEINEMIAKnopp, Robert H.; Illingworth, D. Roger; Stein, Evan A.; Ginsberg, Henry N.; Broyles, Frances E.; Behounek, Bruce D. · American Journal of Therapeutics · 1996

Treatment of type III hyperlipoproteinemia with gemfibrozil to retard progression of coronary artery diseasePeter T. Kuo; Alan C. Wilson; John B. Kostis; Abel B. Moreyra; Harold T. Dodge · 1988

The Metabolic SyndromeAnderson, John J.B.; Prytherch, Susan A.; Sparling, Marilyn; Barrett, Carolyn; Guyton, John R. · Nutrition Today · 2006

Total Knee Arthroplasty With Asymmetric Femoral Condyles and Tibial TrayJohn R. Crockarell Jr; John M. Hicks; R. Jason Schroeder; James L. Guyton; James W. Harkess; David G. Lavelle · 2010

Combination drug therapy for combined hyperlipidemiaJohn R. Guyton · 1999

Benefit versus Risk in Statin TreatmentJohn R. Guyton · 2006

Safety Considerations with Niacin TherapyJohn R. Guyton; Harold E. Bays · 2007

IntroductionPeter O. Kwiterovich Jr.; John R. Guyton · 1998

The use of niacinW. Virgil Brown; Anne C. Goldberg; John R. Guyton; Robert H. Knopp · 2009